Papa John's Put Options Pop After Schnatter Comments

Considering its exposure to China, Nvidia stock is a major loser today

by Josh Selway

Published on Jul 11, 2018 at 3:34 PM

Stocks are sharply lower today following a new round of tariff threats from the Trump administration. Three names making notable moves are pizza chain Papa John's International, Inc. (NASDAQ:PZZA), GPU giant Nvidia Corporation (NASDAQ:NVDA), and pharma issue Achieve Life Sciences Inc (NASDAQ:ACHV). Below, we'll take a closer look at what's moving shares of PZZA, NVDA, and ACHV.

Option Bears Circle as PZZA Stock Hits New Low

PZZA stock is down 3.2% at $49.17, and earlier hit a two-year low of $47.80, after reports surfaced that founder and Chairman John Schnatter used a racial slur during a conference call. Schnatter has since apologized.

Papa John's stock has shed more than 12% year-to-date, and today is on the short-sale restricted list. Still, plenty of shorts are likely cheering, as these bearish bets represent more than 21% of PZZA's float. Elsewhere, Papa John's put options are flying off the shelves at 20 times the average intraday clip, with one option bear seemingly initiating a long put spread at the August 42.50 and 47.50 strikes.

Tariff Headwinds Hit Nvidia Shares

The tariff news is having a particularly strong impact on the tech sector, with chip stocks like NVDA moving lower, last seen trading down 2.1% at $247.84. The shares hit an all-time high of $269.20 on June 14, and the subsequent pullback was contained by the 32-week moving average, which also contained the equity's sharp downturn in late April.

Looking at options open interest for contracts expiring within three months, it appears speculators have remained committed to NVDA calls. That's based on the security's Schaeffer's put/call open interest ratio (SOIR) of 0.84, which ranks just 9 percentage points from a 52-week, call-skewed extreme.

ACHV Stock Tries to Find Life

ACHV stock has popped 11% to trade at $4.04, after the company said it's moving forward with its smoking cessation treatment, cytisine. This follows a meeting with the Food and Drug Administration (FDA), and the company is expecting to conduct a mid-stage trial with 250 smokers later this year. Achieve Life Sciences stock has made a number of large single-day moves in the past year, but has failed to hold the momentum, losing 90% year-over-year.

Streaming Stock Sees a Pre-Earnings Lift
Roku stock is well into overbought territory
2 Energy Stocks That Could Fizzle
Crude oil prices are flirting with YTD highs, but these stocks could dip
What to Make of Rising Analyst Buy Ratings
The percentage of "buy" ratings on SPX stocks just surpassed the 2014 peak

Get Schaeffer's pre-market news bulletin every morning before the bell rings.
It's free to sign up.


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories

Man Who Issued 2008 Warning Urging Investors to Act Now
The time to invest is now, according to one economist.
Call Volume Surges During KNDI, BLNK Stock Rallies
Meanwhile, SCHW is in the red after a downgrade
CODI Stock Trims Early Gains After Tilray Deal
The company just sold its hemp foods unit Manitoba Harvest to weed giant Tilray
Man Who Issued 2008 Warning Urging Investors to Act Now
The time to invest is now, according to one economist.